Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
about
Role of Nutraceuticals in Hypolipidemic TherapyMeta-analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol.Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjects.Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trialPolicosanols as nutraceuticals: fact or fiction.Policosanol attenuates statin-induced increases in serum proprotein convertase subtilisin/kexin type 9 when combined with atorvastatin.Pharmacotherapy for dyslipidaemia--current therapies and future agents.Complementary and alternative therapies for the management of dyslipidemia.Effects of Armolipid Plus on small dense LDL particles in a sample of patients affected by familial combined hyperlipidemia.Anti-Aging and Tissue Regeneration Ability of Policosanol Along with Lipid-Lowering Effect in Hyperlipidemic Zebrafish via Enhancement of High-Density Lipoprotein Functionality.Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial.Effects of Dietary Octacosanol on Growth Performance, Carcass Characteristics and Meat Quality of Broiler Chicks.Functional foods for dyslipidaemia and cardiovascular risk prevention.Consumption of policosanol enhances HDL functionality via CETP inhibition and reduces blood pressure and visceral fat in young and middle-aged subjects.Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.Nutraceutical and functional scenario of wheat straw.Plant-based foods as a source of lipotropes for human nutrition: a survey of in vivo studies.Octacosanol restores stress-affected sleep in mice by alleviating stress.Triacylglycerols and aliphatic alcohols from fruits of three Tunisian Pistacia lentiscus populations.Characterization of rice bran wax policosanol and its nanoemulsion formulation.Effects of emulsified policosanols with different chain lengths on cholesterol metabolism in heterozygous LDL receptor-deficient mice.In silico toxicological screening of natural products.Effect of triacontanol on the pharmacokinetics of docetaxel in rats associated with induction of cytochrome P450 3A1/2.A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial.Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study.Lack of effect of sugar cane and sunflower seed policosanols on plasma cholesterol in rabbits.Beeswax (E 901) as a glazing agent and as carrier for flavours - Scientific Opinion of the Panel on Food additives, Flavourings, Processing aids and Materials in Contact with Food (AFC)Metabolite Profiling of Peppers of Various Colors Reveals Relationships Between Tocopherol, Carotenoid, and Phytosterol Content.LDL-cholesterol-lowering effect of a dietary supplement with plant extracts in subjects with moderate hypercholesterolemia.Policosanol composition, antioxidant and anti-arthritic activities of milk thistle (Silybium marianum L.) oil at different seed maturity stages.Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study.
P2860
Q26776125-EB28BD2D-0065-4A64-8E6E-ABC6B12745E9Q30848020-D9F1D5E4-6980-440F-833D-383DB4BA6C2BQ33795072-4C0BFE64-1284-4036-A1E5-252E80E1B282Q33988933-38A043C8-61DC-41C2-9B09-727CE5935777Q34105246-3334A08B-3292-4CA3-9A48-FE558BC9E7B1Q34588435-DBC9958D-B679-4858-8D2D-4615367FDA6FQ35574960-EF73D9BB-3579-4B71-A557-DA695A6A6C15Q36626326-FCE4F6FB-4273-4921-A457-30CA7FF1CB6BQ36767154-CFE72522-6EEE-42CD-881B-6E7C6B2E51F0Q36825952-1B9B6505-F93D-4150-9B8B-08AF23AF0326Q36844596-EA398DCE-41F5-49C7-9A37-763070AFD923Q37215248-91CA957B-68D5-4935-98B5-239D1AA74702Q37651472-A5196B7D-B884-4D08-A973-7FFC4B25E15AQ37714141-F699C76D-D9E7-47BB-B6D5-DA6EE4BCC23AQ38025713-E5BAAB2F-96BD-4B4F-97E3-BA8D6F595F29Q38065236-122EDAC4-E82D-49A0-8358-76C4208F7BFCQ38102732-25E2E9F0-5D71-48D9-A596-CC0CF8B5D5D8Q38615268-68083069-8CEC-4ED9-82DC-C95CF1E78293Q39531707-C6965AEF-A937-4662-9F5F-141DEAE162B3Q39754160-04708411-A4B7-49B2-82E1-3FE4C45567A7Q40030121-60A385F7-2126-43DC-8694-31560BEB95BAQ43215869-CC4B7FC5-BC0D-4E6C-8D5A-7BD0B70C4BF1Q43442709-1BAF5666-9F55-4D8B-9017-0935B2877672Q43585228-E23563A8-7F65-4ED2-9EC6-2CAF7C8DF06CQ44436736-301ACFD7-04F2-4E14-A3B2-ECBAACDDF222Q46269137-E8FF3A16-72F5-4BFD-9420-8D3D1DEC09CBQ47145150-CD3CD83A-D302-4F64-BE27-0E0ADCC07BF4Q48325558-6F17F36E-C647-4AE0-8EE6-8DD4FE2A842CQ50512548-9580A1E1-ACD7-4A73-BD2C-8356339DABCEQ53692464-D5285F63-FCC4-4D3A-BF18-730117E98C78Q55345298-2BF183C4-77B5-4B5F-9BDB-ECC053D8539A
P2860
Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@ast
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@en
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@nl
type
label
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@ast
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@en
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@nl
prefLabel
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@ast
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@en
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@nl
P356
P1476
Policosanol: clinical pharmaco ...... of a new lipid-lowering agent.
@en
P2093
Heiner K Berthold
Ioanna Gouni-Berthold
P304
P356
10.1067/MHJ.2002.119997
P407
P577
2002-02-01T00:00:00Z